tPa/PAI-1 inhibitors (Servier)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NametPa/PAI-1 inhibitors (Servier)
Drug Alias NameS-18246
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasminogen inhibitorsPlasminogen activator inhibitor 1 inhibitors
TargetsPlasminogen activator inhibitor 1Plasminogen
Therapy Area/IndicationsInflammationDiabetes Mellitus, Type 2Thrombosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaboratoires Servier
Active IndicationsN/A
Inactive IndicationsInflammationDiabetes Mellitus, Type 2Thrombosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A